$GAN
GAN Ltd Stock $gan

$gan Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040143 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$30.72M	$29.82M	$32.12M
YoY Change	-16.87%	-7.17%	-0.46%
Cost Of Revenue	$9.812M	$9.240M	$9.435M
YoY Change	-2.23%	-2.07%	-12.65%
Gross Profit	$20.90M	$20.58M	$22.69M
YoY Change	-22.33%	-9.28%	5.67%
Gross Profit Margin	68.05%	69.02%	70.63%
Selling, General & Admin	$16.83M	$14.26M	$16.94M
YoY Change	-22.13%	-15.85%	-8.64%
% of Gross Profit	80.51%	69.27%	74.68%
Research & Development	$8.277M	$9.150M	$4.998M
YoY Change	14.88%	83.07%	-8.99%
% of Gross Profit	39.6%	44.46%	22.03%
Depreciation & Amortization	$4.379M	$453.0K	$5.893M
YoY Change	-31.73%	-92.31%	29.23%
% of Gross Profit	20.95%	2.2%	25.98%
Operating Expenses	$29.49M	$14.26M	$16.94M
YoY Change	-16.31%	-15.85%	-40.76%
Operating Profit	-$8.582M	-$7.170M	-$5.148M
YoY Change	3.12%	39.28%	-27.8%
Interest Expense		$1.264M	$1.450M
YoY Change		-12.83%
% of Operating Profit
Other Income/Expense, Net	-$107.0K		$13.00K
YoY Change	-108.98%
Pretax Income	-$9.623M	-$8.434M	-$6.585M
YoY Change	-93.33%	28.08%	-7.64%
Income Tax	-$247.0K	-$274.0K	$356.0K
% Of Pretax Income
Net Earnings	-$9.376M	-$8.160M	-$6.941M
YoY Change	-93.65%	17.56%	-20.02%
Net Earnings / Revenue	-30.53%	-27.37%	-21.61%
Basic Earnings Per Share		-$0.18	-$0.16
Diluted Earnings Per Share	-$0.21	-$0.18	-$164.3K
COMMON SHARES
Basic Shares Outstanding	44.71M shares	44.68M shares	42.08M shares
Diluted Shares Outstanding		44.70M shares	42.24M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.58M	$39.20M	$41.79M
YoY Change	-15.99%	-6.19%	-16.93%
Cash & Equivalents	$38.60M	$39.20M	$41.79M
Short-Term Investments
Other Short-Term Assets	$3.202M	$4.086M	$3.503M
YoY Change	5.29%	16.64%	-26.88%
Inventory
Prepaid Expenses	$3.344M	$3.302M	$4.432M
Receivables	$11.42M	$9.168M	$13.14M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$56.54M	$55.77M	$62.86M
YoY Change	-16.4%	-11.28%	0.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.159M	$3.017M	$2.548M
YoY Change	45.93%	18.41%
Goodwill			$99.09M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.895M	$5.189M	$4.336M
YoY Change	57.37%	19.67%	-66.69%
Total Long-Term Assets	$30.96M	$32.89M	$167.2M
YoY Change	-12.66%	-80.33%	-21.81%
TOTAL ASSETS
Total Short-Term Assets	$56.54M	$55.77M	$62.86M
Total Long-Term Assets	$30.96M	$32.89M	$167.2M
Total Assets	$87.50M	$88.66M	$230.1M
YoY Change	-15.11%	-61.47%	-16.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.971M	$5.449M	$6.331M
YoY Change	8.3%	-13.93%	36.24%
Accrued Expenses	$12.68M	$11.90M	$2.674M
YoY Change	15.62%	345.03%	-81.31%
Deferred Revenue	$10.19M	$9.467M	$8.946M
YoY Change	-4.66%	5.82%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$36.72M	$32.47M	$26.67M
YoY Change	12.89%	21.75%	-19.96%
LONG-TERM LIABILITIES
Long-Term Debt	$42.19M	$41.10M	$27.86M
YoY Change	49.83%	47.55%
Other Long-Term Liabilities	$5.825M	$2.508M	$1.517M
YoY Change	174.12%	65.33%	-11.6%
Total Long-Term Liabilities	$5.825M	$2.508M	$1.517M
YoY Change	174.12%	65.33%	-11.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.72M	$32.47M	$26.67M
Total Long-Term Liabilities	$5.825M	$2.508M	$1.517M
Total Liabilities	$92.11M	$86.64M	$77.74M
YoY Change	11.9%	11.45%	108.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$309.3M	-$299.9M	-$127.2M
YoY Change	12.51%	135.86%
Common Stock	$337.0M	$335.8M	$327.8M
YoY Change	2.3%	2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.604M	$2.020M	$152.4M
YoY Change
Total Liabilities & Shareholders Equity	$87.50M	$88.66M	$230.1M
YoY Change	-15.11%	-61.47%	-16.74%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$9.376M	-$8.160M	-$6.941M
YoY Change	-93.65%	17.56%	-20.02%
Depreciation, Depletion And Amortization	$4.379M	$453.0K	$5.893M
YoY Change	-31.73%	-92.31%	29.23%
Cash From Operating Activities	$75.00K	-$2.290M	$628.0K
YoY Change	-96.75%	-464.65%	-135.14%
INVESTING ACTIVITIES
Capital Expenditures	$2.043M	$1.200M	-$5.004M
YoY Change	87.6%	-123.98%	40.72%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$2.043M	-$1.200M	-$5.004M
YoY Change	28.57%	-76.02%	4620.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	94.00K	0.000	493.0K
YoY Change	-1040.0%	-100.0%	6.71%
NET CHANGE
Cash From Operating Activities	75.00K	-2.290M	628.0K
Cash From Investing Activities	-2.043M	-1.200M	-5.004M
Cash From Financing Activities	94.00K	0.000	493.0K
Net Change In Cash	-1.874M	-3.490M	-3.883M
YoY Change	-363.57%	-10.12%	171.35%
FREE CASH FLOW
Cash From Operating Activities	$75.00K	-$2.290M	$628.0K
Capital Expenditures	$2.043M	$1.200M	-$5.004M
Free Cash Flow	-$1.968M	-$3.490M	$5.632M
YoY Change	-261.18%	-161.97%	218.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	28888000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges		usd
	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001799332
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt		usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	GAN	Payment Of Content Licensing Fee PaymentOfContentLicensingFee		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	GAN	Proceed From Issuance Of Long Term Debt ProceedFromIssuanceOfLongTermDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	GAN	Intangible Assets Acquired In Business Acquisition IntangibleAssetsAcquiredInBusinessAcquisition		usd
	GAN	Rightofuse Asset Obtained In Exchange For New Operating Lease Liability RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability		usd
	GAN	Contract Asset And Contingent Liability Related To Synthetic Equity ContractAssetAndContingentLiabilityRelatedToSyntheticEquity		usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts		usd
CY2022Q3	us-gaap	Restructuring Costs RestructuringCosts		usd
	us-gaap	Restructuring Costs RestructuringCosts		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39274
	dei	Entity Registrant Name EntityRegistrantName	GAN Limited
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Spectrum Center Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1900
	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92618
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	565-0550
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not applicable
	dei	Security12b Title Security12bTitle	Ordinary shares, par value $0.01
	dei	Trading Symbol TradingSymbol	GAN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44714448	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39212000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45920000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	146000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	250000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9168000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13808000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3302000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4861000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	4086000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3041000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	55768000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	67630000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7972000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6749000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15293000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24955000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4438000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	234000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5189000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3512000	usd
CY2023Q3	us-gaap	Assets Assets	88660000	usd
CY2022Q4	us-gaap	Assets Assets	103080000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5449000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6437000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9570000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8750000	usd
CY2023Q3	GAN	Accrued Content License Fees AccruedContentLicenseFees	1577000	usd
CY2022Q4	GAN	Accrued Content License Fees AccruedContentLicenseFees	2214000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9467000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10683000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	195000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5659000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4253000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	32473000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32532000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4073000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4218000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	41056000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	28157000	usd
CY2023Q3	GAN	Content Licensing Liability ContentLicensingLiability	2800000	usd
CY2022Q4	GAN	Content Licensing Liability ContentLicensingLiability	15280000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3730000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2508000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2125000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	86640000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	82312000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44698931	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44698931	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42894211	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42894211	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	447000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	429000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	335321000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	328998000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-299929000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274861000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33819000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33798000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2020000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88660000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	103080000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29817000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32120000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98704000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104581000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	31598000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7196000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6781000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21704000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20292000	usd
CY2023Q3	GAN	Product And Technology Expense ProductAndTechnologyExpense	9150000	usd
CY2022Q3	GAN	Product And Technology Expense ProductAndTechnologyExpense	7571000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	29966000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	24928000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27095000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27307000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	28861000	usd
	us-gaap	Restructuring Charges RestructuringCharges	1771000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4339000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5893000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12783000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16862000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	36987000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	37268000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	120436000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	151619000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7170000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5148000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21732000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47038000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1264000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1450000	usd
	us-gaap	Interest Expense InterestExpense	3885000	usd
	us-gaap	Interest Expense InterestExpense	2521000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	283000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8434000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6585000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24683000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-49276000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-274000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	356000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	385000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8160000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6941000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25068000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49789000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.18
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44699951	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44699951	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42237226	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42237226	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43949594	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43949594	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42263462	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42263462	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8160000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6941000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25068000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49789000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1142000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12201000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-21000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-28661000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9302000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19142000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25089000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78450000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	966000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1382000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	79000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	65000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-18409000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	155000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1621000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1963000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9939000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8160000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1142000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1386000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-3000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2020000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	224037000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4264000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1316000	usd
CY2022Q1	GAN	Adjustments To Additional Paid In Capital Accrued Liability Settled Through Issuance Of Shares AdjustmentsToAdditionalPaidInCapitalAccruedLiabilitySettledThroughIssuanceOfShares	444000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	217034000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-38349000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12196000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2659000	usd
CY2022Q2	GAN	Adjustments To Additional Paid In Capital Accrued Liability Settled Through Issuance Of Shares AdjustmentsToAdditionalPaidInCapitalAccruedLiabilitySettledThroughIssuanceOfShares	469000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1006000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	395000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	169006000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	169006000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6941000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6941000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12201000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2140000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-135000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	325000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	169000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	152363000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	152363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25068000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49789000	usd
	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	11594000	usd
	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	15837000	usd
	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	1188000	usd
	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	1025000	usd
	GAN	Noncash Interest And Amortization Of Debt Discount And Debt Issuance Costs NoncashInterestAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	2845000	usd
	GAN	Noncash Interest And Amortization Of Debt Discount And Debt Issuance Costs NoncashInterestAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	280000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4699000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5671000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9717000	usd
	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	8784000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	28861000	usd
	GAN	Deferred Income Tax DeferredIncomeTax	-117000	usd
	GAN	Deferred Income Tax DeferredIncomeTax	541000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-288000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	102000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	22000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4791000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5189000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1560000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1226000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1053000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	265000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4452000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2552000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-996000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1730000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	859000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4174000	usd
	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees	-645000	usd
	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees	-1689000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1158000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1296000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2043000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-387000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1593000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1389000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3640000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3559000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2753000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9242000	usd
	GAN	Payment Of Content Licensing Fee PaymentOfContentLicensingFee	5500000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	412000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1115000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1607000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1657000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4772000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17514000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	30000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	720000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	66000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	169000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	409000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1006000	usd
	GAN	Proceed From Issuance Of Long Term Debt ProceedFromIssuanceOfLongTermDebt	4733000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3137000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2425000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1253000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27458000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	451000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4074000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6708000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2311000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45920000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39477000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39212000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41788000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1068000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	184000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	690000	usd
	GAN	Intangible Assets Acquired In Business Acquisition IntangibleAssetsAcquiredInBusinessAcquisition	26244000	usd
	GAN	Rightofuse Asset Obtained In Exchange For New Operating Lease Liability RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability	4471000	usd
	GAN	Contract Asset And Contingent Liability Related To Synthetic Equity ContractAssetAndContingentLiabilityRelatedToSyntheticEquity	1143000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_807_eus-gaap--NatureOfOperations_zFMwi3QPATq1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 </b>— <b><span id="xdx_82C_zq8SzMPZgHie">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAN Limited (the “Parent,” and with its subsidiaries, collectively the “Company”) is an exempted company limited by shares, incorporated and registered in Bermuda.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a business-to-business (“B2B”) supplier of a proprietary gaming system, GameSTACK™ (“GameSTACK”), which is used predominately by the U.S. land-based casino industry. For its B2B customers, GameSTACK is a turnkey technology solution for regulated real money internet gambling (“real money iGaming” or “RMiG”), online sports gaming, and virtual simulated gaming (“SIM”). In addition, the Company’s B2B segment offers GAN Sports, an in-house online and retail sports betting technology platform, through internet connected self-service kiosks deployed at casino properties and mobile solutions. The Company is also a business-to-consumer (“B2C”) developer and operator of an online sports betting and casino platform under its “Coolbet” brand, providing international users with access through www.coolbet.com to its sportsbook, casino games and poker products. The Company operates its B2C segment in markets across Northern Europe, Latin America, and Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-299900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39200000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9500000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	42000000.0	usd
CY2023Q2	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.080	pure
CY2023Q2	GAN	Financial Covenant Requirement Minimum Liquidity FinancialCovenantRequirementMinimumLiquidity	10000000.0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z1HwPOlaZcLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_z5IycZjD0pc9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Due to the inherent uncertainties involved in making estimates, actual results could differ from the original estimates, and may require significant adjustments to these reported balances in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	155000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	684000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1169000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-494000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zZ4ojn4WXzzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zJK6KqhTKc8k">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of its cash and trade receivables. The Company holds cash deposits in foreign countries, primarily in Northern Europe and Latin America, of approximately $<span id="xdx_902_eus-gaap--Deposits_iI_pn5n6_c20230930__srt--StatementGeographicalAxis__custom--NorthernEuropeAndLatinAmericaMember_zseEszf67Ri6" title="Cash deposits">32.2</span> million, which are subject to local banking laws and may bear higher or lower risk than cash deposited in the United States. Cash held in the United States is maintained in a major financial institution in excess of federally insured limits. As part of our cash management processes, the Company performs periodic evaluations of the credit standing of the financial institutions and we have not sustained any credit losses from instruments held at these financial institutions. Additionally, the Company maintains an allowance for potential credit losses, but historically has not experienced any significant losses related to individual customers or groups of customers in any particular geographic area.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	8900000	usd
CY2023Q3	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1427000	usd
CY2022Q4	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1628000	usd
CY2023Q3	GAN	Number Of Third Party Gaming Products Available NumberOfThirdPartyGamingProductsAvailable	5700	integer
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9467000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10683000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7989000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6449000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4972000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3599000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3017000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2850000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	453000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	312000	usd
	us-gaap	Depreciation Depreciation	1188000	usd
	us-gaap	Depreciation Depreciation	1025000	usd
CY2023Q3	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	8345000	usd
CY2022Q4	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	6857000	usd
CY2023Q3	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	1885000	usd
CY2022Q4	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	732000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	10230000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	7589000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2258000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	840000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7972000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6749000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	485000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1438000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1461000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4552000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48846000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33553000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15293000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48727000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23772000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24955000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3401000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4135000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10134000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11285000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3403000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2989000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2967000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2512000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1820000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1602000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15293000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.095	pure
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2400000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	27600000	usd
CY2023Q2	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	7300000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	8800000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	42000000.0	usd
CY2023Q2	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.080	pure
CY2023Q2	GAN	Debt Instrument Interest Rate For Exit Fee DebtInstrumentInterestRateForExitFee	0.025	pure
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3100000	usd
CY2023Q2	GAN	Financial Covenant Requirement Minimum Liquidity FinancialCovenantRequirementMinimumLiquidity	10000000.0	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1022	pure
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	43754000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-2698000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	41056000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1281000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1071000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	240000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	185000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3587000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1735000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	765000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	280000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3447155	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.12
	GAN	Weighted Average Contractual Term Outstanding Beginning WeightedAverageContractualTermOutstandingBeginning	P6Y7M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1139000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	612081	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5129	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	530714	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	15.15
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3523393	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.65
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M13D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1414000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2471947	shares
CY2023Q3	GAN	Weighted Average Exercise Price Options Exercisable At End Of Period WeightedAverageExercisePriceOptionsExercisableAtEndOfPeriod	8.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M9D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	414000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.74
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.76
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.13
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0070	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0051	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y14D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0252	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	us-gaap	Share Price SharePrice	0.01
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50	pure
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	173000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	133000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	528000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	454000	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	13000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9718000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	283000	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	8784000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	283000	usd
	GAN	Gains On Extinguishment Of Debt GainsOnExtinguishmentOfDebt	9700000	usd
CY2023Q2	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	8800000	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5865578	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5240901	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5865578	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5240901	shares
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29817000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32120000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98704000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104581000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2607000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	459000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2117000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1874000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3039000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1467000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3039000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1467000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	301000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	250000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	686000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	775000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29817000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32120000	usd
CY2023Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	9242000	usd
CY2022Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	9435000	usd
CY2023Q3	GAN	Segment Contribution SegmentContribution	20575000	usd
CY2022Q3	GAN	Segment Contribution SegmentContribution	22685000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98704000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104581000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	28888000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	31598000	usd
	GAN	Segment Contribution SegmentContribution	69816000	usd
	GAN	Segment Contribution SegmentContribution	72983000	usd
CY2023Q3	GAN	Segment Contribution SegmentContribution	20575000	usd
CY2022Q3	GAN	Segment Contribution SegmentContribution	22685000	usd
	GAN	Segment Contribution SegmentContribution	69816000	usd
	GAN	Segment Contribution SegmentContribution	72983000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7196000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6781000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21704000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20292000	usd
CY2023Q3	GAN	Product And Technology Expense ProductAndTechnologyExpense	9150000	usd
CY2022Q3	GAN	Product And Technology Expense ProductAndTechnologyExpense	7571000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	29966000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	24928000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7060000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7588000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27095000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27307000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	28861000	usd
	us-gaap	Restructuring Costs RestructuringCosts	1771000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4339000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5893000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12783000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16862000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1264000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1450000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3885000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2521000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	283000	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-8434000	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-6585000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-24683000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-49276000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29817000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32120000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98704000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104581000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29817000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32120000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98704000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104581000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.032	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.054	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.016	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.010	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
	us-gaap	Restructuring Charges RestructuringCharges	1800000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4438000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	234000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	195000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3730000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4481000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	195000	usd
CY2023Q3	GAN	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	909000	usd
CY2022Q4	GAN	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	1033000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	266000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	98000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	523000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	360000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	281000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1134000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1143000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1154000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1165000	usd
CY2023Q3	GAN	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	671000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5548000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1068000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4481000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	432000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	373000	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00

Files In Submission

Name	View Source	Status
0001493152-23-040143-index-headers.html	Edgar Link	pending
0001493152-23-040143-index.html	Edgar Link	pending
0001493152-23-040143.txt	Edgar Link	pending
0001493152-23-040143-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gan-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
gan-20230930_cal.xml	Edgar Link	unprocessable
gan-20230930_def.xml	Edgar Link	unprocessable
gan-20230930_lab.xml	Edgar Link	unprocessable
gan-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GAN
GAN Ltd Stock $gan

2023 Q4 Form 10-Q Financial Statement

#000149315223040143 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN GAN Ltd Stock $gan

2023 Q4 Form 10-Q Financial Statement

#000149315223040143 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN
GAN Ltd Stock $gan